首页> 外文会议>NATO Advanced Research Workshop on Technological and Medical Implications of Metabolic Control Analysis Visegrad, Hungary 10-16 April 1999 >The Control Strength of Glucokinase in hepatocytes: A Predictor of Metabolic Defects in Maturity Onset Diabetes of the Young, Type 2
【24h】

The Control Strength of Glucokinase in hepatocytes: A Predictor of Metabolic Defects in Maturity Onset Diabetes of the Young, Type 2

机译:肝细胞中葡萄糖激酶的控制强度:年轻的2型糖尿病的成熟发病糖尿病代谢缺陷的预测因子。

获取原文
获取原文并翻译 | 示例

摘要

Maturity-onset diabetes of the young (MODY) is a heterogeneous sub-type of diabetes mellitus that was originally defined as "fasting hyperglycaemia diagnsed before age 25 which could be treated without insulin for more than 2 years" (Tattersall & Fajans, 1975). In addition to the early age of onset, the main distingushing feature relative to the common forms of non-insulin-dependent diabetes mellitus is that it is characterized by autosomal dominant inheritance (Hattersley, 1998; Tattersall, 1998). Mutations in five genes havee been shown to cause it in addition to as yet unidentified forms of the disease (Chevre et al., 1998). The first of these that was identified was the glucokinase gene (MODY-2), followed by hepatocyte nuclear factor 4 alpha and hepatocyte nuclear factor 1 alpha , and more recently the genes for insulin-promoter factor 1 and hepatocyte nuclear factor 1 beta .
机译:年轻人的成熟期糖尿病(MODY)是糖尿病的一种异质亚型,最初被定义为“在25岁之前诊断为空腹高血糖症,可以在不使用胰岛素的情况下治疗2年以上”(Tattersall和Fajans,1975年) 。除发病年龄较早外,相对于非胰岛素依赖型糖尿病的常见形式,主要区别在于其以常染色体显性遗传为特征(Hattersley,1998; Tattersall,1998)。除尚未确定的疾病形式外,还显示了五个基因的突变会引起该疾病(Chevre等,1998)。首先被鉴定的是葡萄糖激酶基因(MODY-2),其次是肝细胞核因子4 alpha和肝细胞核因子1 alpha,最近是胰岛素促进因子1和肝细胞核因子1 beta的基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号